Egetis Therapeutics AB (publ) (LON:0ABW)
London
· Delayed Price · Currency is GBP · Price in SEK 4.875
-0.275 (-5.34%)
At close: Feb 21, 2025
Egetis Therapeutics AB Employees
Egetis Therapeutics AB had 28 employees as of December 31, 2023. The number of employees increased by 11 or 64.71% compared to the previous year.
Employees
28
Change (1Y)
11
Growth (1Y)
64.71%
Revenue / Employee
128.08K GBP
Profits / Employee
-602.27K GBP
Market Cap
130.30M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 28 | 11 | 64.71% |
| Dec 31, 2022 | 17 | 5 | 41.67% |
| Dec 31, 2021 | 12 | 2 | 20.00% |
| Dec 31, 2020 | 10 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 89,900 |
| Shell | 103,000 |
| HSBC Holdings | 220,861 |
| Unilever | 128,377 |
| Rio Tinto Group | 57,000 |
| RELX PLC | 36,400 |
| BP p.l.c. | 87,800 |
| British American Tobacco p.l.c. | 46,725 |